Nigel Wilson

Director Financiero/CFO en

Buhler Ltd.

Finance

Distribution Services

Consumer Services

Perfil

Nigel Wilson currently works at Cambridge Innovation Capital Ltd, as Chairman from 2025 and Buhler Ltd., as Finance Director.
Dr. Wilson received his doctorate degree from Massachusetts Institute of Technology and undergraduate degree and graduate degree from the University of Essex.

Cargos activos de Nigel Wilson

Empresas	Cargo	Inicio
Buhler Ltd. Buhler Ltd. Wholesale DistributorsDistribution Services Manufactures and supplies wet dispersion, milling and mixing systems	Director Financiero/CFO	11/11/2010
Cambridge Innovation Capital Ltd Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments.	Presidente	11/09/2025

Todos los cargos activos de Nigel Wilson

Formación de Nigel Wilson.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Nigel Wilson.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Buhler Ltd. Buhler Ltd. Wholesale DistributorsDistribution Services Manufactures and supplies wet dispersion, milling and mixing systems	Distribution Services
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
University of Essex University of Essex Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cambridge Innovation Capital Ltd Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments.	Finance